Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Tanabe Pharma America, Inc.
Turning Point Therapeutics, Inc.
Hoffmann-La Roche
EpicentRx, Inc.
Institut Bergonié
Eli Lilly and Company
Merck Sharp & Dohme LLC